Neuro Talk: Accelerating Drug Discovery Through the Parkinson’s Virtual Biotech

Launching a new Parkinson’s disease (PD) drug can take years and cost upwards of one billion dollars.

In our latest Neuro Talk, John L. Lehr, president and CEO of the Parkinson's Foundation, and Arthur Roach, director of the Parkinson’s Virtual Biotech at Parkinson’s UK, discuss how the Parkinson’s Virtual Biotech is accelerating PD drug discovery and development. This international collaboration will help find the next life-saving Parkinson’s drug in years, not decades.